- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Florida Cancer Specialists & Research Institute Ranked Among Top Performing Oncology Practices in the Country for Quality, Cost Saving Measures
Key quality and savings metrics as measured within the most recent performance period from The Centers for Medicare & Medicaid Innovation (CMMI) for the Oncology Care Model (OCM) demonstrated Florida Cancer Specialists & Research Institute as a top performing oncology practice nationwide.
Fort Myers, Florida — Florida Cancer Specialists & Research Institute (FCS) reported key quality and savings metrics, as measured within the most recent performance period from The Centers for Medicare & Medicaid Innovation (CMMI) for the Oncology Care Model (OCM), with Medicare savings of approximately $31.7 million over the last 6-month performance period and more than $140 million in total savings since the OCM launched in 2016.
In this most recent feedback report issued by CMMI, the number of inpatient hospital admissions for FCS was 8% lower than other OCM practices, and the number of emergency room visits not leading to admission was 21% lower than other OCM practices in the same patient risk quartile.
At the same time, FCS has demonstrated value-based outcomes and episode-based payment initiatives partnering with commercial payers, Accountable Care Organizations, and Medicaid-Managed Care Organizations in markets across the state.
“Our value-based practice initiatives at FCS are programmatic, intentional and thoughtfully designed to be organized squarely around the patient, yielding consistent results that outpace industry benchmarks and made good on our commitment to prioritize patient outcomes and quality,” stated FCS chief executive officer Nathan H. Walcker. “I could not be prouder of our entire team and their steadfast commitment to delivering value-based oncology care in communities across our great state of Florida.”
LLMs Show Promise, But Challenges Remain in Improving Inefficient Clinical Trial Screening
July 31st 2025Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of structured electronic health record data to capture all necessary criteria.
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More
